Synthesis and characterization of imidazopyrazine derivatives as VAV1 inhibitors

被引:0
|
作者
Gerspacher, Marc [1 ]
Skaanderup, Philip [1 ]
Imbach-Weese, Patricia [1 ]
Metoul, Lionel Doumampouom [1 ]
Roehn-Carnemolla, Esther [1 ]
Arz, Dorothee [1 ]
Garlot, Audrey-Laure [1 ]
Remond, Anne-Catherine [1 ]
Eric, Vangrevelinghe [1 ]
Knapp, Mark [2 ]
Lingel, Andreas [1 ]
Stucke, Volker [1 ]
Chene, Patrick [1 ]
Hofmann, Francesco [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst BioMed Res Basel, Basel, Switzerland
[2] Novartis Inst BioMed Res, Emeryville, CA USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
101
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Imidazopyrazine Derivatives As Inhibitors of mTOR
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 498 - 499
  • [2] Vav1 in differentiation of tumoral promyelocytes
    Bertagnolo, Valeria
    Brugnoli, Federica
    Grassilli, Silvia
    Nika, Ervin
    Capitani, Silvano
    CELLULAR SIGNALLING, 2012, 24 (03) : 612 - 620
  • [3] Vav1: Friend and Foe of Cancer
    Guo, Fukun
    Zheng, Yi
    TRENDS IN CELL BIOLOGY, 2017, 27 (12) : 879 - 880
  • [4] QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors
    Leng, Y.
    Lu, T.
    Yuan, H. L.
    Liu, H. C.
    Lu, S.
    Zhang, W. W.
    Jiang, Y. L.
    Chen, Y. D.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2012, 23 (7-8) : 705 - 730
  • [5] VAV1 - A new target in pancreatic cancer?
    DeNicola, G
    Tuveson, DA
    CANCER BIOLOGY & THERAPY, 2005, 4 (05) : 509 - 511
  • [6] Vav1 in hematologic neoplasms, a mini reviewa
    Oberley, Matthew J.
    Wang, Deng-Shun
    Yang, David T.
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 1 - 8
  • [7] An unexpected tumor suppressor role for VAV1(a)
    Bustelo, Xose R.
    Francisco Lorenzo-Martin, L.
    Cuadrado, Myriam
    Fernandez-Pisonero, Isabel
    Robles-Valero, Javier
    MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (03):
  • [8] Vav1 as a Central Regulator of Invadopodia Assembly
    Razidlo, Gina L.
    Schroeder, Barbara
    Chen, Jing
    Billadeau, Daniel D.
    McNiven, Mark A.
    CURRENT BIOLOGY, 2014, 24 (01) : 86 - 93
  • [9] Vav1 is a component of transcriptionally active complexes
    Houlard, M
    Arudchandran, R
    Regnier-Ricard, F
    Germani, A
    Gisselbrecht, S
    Blank, U
    Rivera, J
    Varin-Blank, N
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09): : 1115 - 1127
  • [10] Vav1 and Vav 3 differentially impact osteoclast formation and function.
    Faccio, R
    Swat, W
    Wang, MWH
    Zallone, A
    Teitelbaum, SL
    Ross, FP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S454 - S454